Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers

Autor: Odintsov, Igor, Mattar, Marissa S., Lui, Allan J.W., Offin, Michael, Kurzatkowski, Christopher, Delasos, Lukas, Khodos, Inna, Asher, Marina, Daly, Robert M., Rekhtman, Natasha, de Stanchina, Elisa, Ganji, Gopinath, Ladanyi, Marc, Somwar, Romel
Zdroj: In Journal of Thoracic Oncology July 2021 16(7):1149-1165
Databáze: ScienceDirect